[Form 4] Vaxart, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Vaxart, Inc. director Watson W. Mark reported compensation-related equity awards. He acquired 39,400 shares of common stock at no cost in connection with restricted stock units, and a grant of 78,700 stock options with a $0.5149 exercise price, expiring July 16, 2036. Both the shares and options are scheduled to vest on the earlier of the date immediately prior to Vaxart’s 2027 annual stockholders’ meeting and July 16, 2027. Following these awards, he directly holds 173,525 common shares and 78,700 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Watson W. Mark
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (right to buy) | 78,700 | $0.00 | -- |
| Grant/Award | Common Stock | 39,400 | $0.00 | -- |
Holdings After Transaction:
Stock Options (right to buy) — 78,700 shares (Direct);
Common Stock — 173,525 shares (Direct)
Footnotes (1)
- Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant. The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant.
Key Figures
Common shares granted: 39,400 shares
Stock options granted: 78,700 options
Option exercise price: $0.5149 per share
+3 more
6 metrics
Common shares granted
39,400 shares
Grant related to restricted stock units on 2026-07-16
Stock options granted
78,700 options
Director option award on 2026-07-16
Option exercise price
$0.5149 per share
Conversion or exercise price for 78,700 options
Option expiration date
2036-07-16
Expiration for stock options granted on 2026-07-16
Shares after transaction
173,525 shares
Total common stock directly held after equity grants
Vesting latest date
July 16, 2027
Latest vesting date for both RSU-related shares and options
Key Terms
restricted stock units, Stock Options (right to buy), exercise price, annual meeting of stockholders
4 terms
restricted stock units financial
"Grant of shares upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Options (right to buy) financial
"security_title": "Stock Options (right to buy)""
exercise price financial
"conversion_or_exercise_price": "0.5149""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting of stockholders financial
"earlier of the date immediately prior of the 2027 annual meeting of stockholders"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity awards were reported at Vaxart (VXRT)?
Director Watson W. Mark received equity awards consisting of 39,400 common shares and 78,700 stock options. These are compensation-related grants, not open-market purchases, and were reported as acquisitions on the insider ownership report.
What are the terms of the new stock options granted at Vaxart (VXRT)?
The director was granted 78,700 stock options with an exercise price of $0.5149 per share, expiring on July 16, 2036. These options relate to an equal number of common shares and vest based on a defined future schedule.
When do the new Vaxart (VXRT) equity awards vest?
Both the 39,400-share award tied to restricted stock units and the 78,700 stock options vest on the earlier of the date immediately prior to Vaxart’s 2027 annual stockholders’ meeting and July 16, 2027, the first anniversary of the grant.
Were the Vaxart (VXRT) insider transactions under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is marked as false, indicating these compensation grants were not reported as made under a Rule 10b5-1 trading plan. They are standard director equity awards rather than pre-planned market trades.